Think of a football field. And those eight-figure quarterback contracts. But instead of gridiron and gunslingers, picture a sophisticated machine that delivers just the right amount of pressure to sack certain types of cancer, without collateral damage.
That’s a way to understand the size, cost and performance of the proton therapy systems made by Palo Alto’s Varian Medical Systems. So when Varian’s chief counsel for particle therapy Alison Nichols negotiates a sale and setup, it’s not just for a product that just gets shipped out to a customer or built on a plot of land.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
